...
首页> 外文期刊>International Journal of Environmental Research and Public Health >Association between the Angiotensin-Converting Enzyme (ACE) Genetic Polymorphism and Diabetic Retinopathy—A Meta-Analysis Comprising 10,168 Subjects
【24h】

Association between the Angiotensin-Converting Enzyme (ACE) Genetic Polymorphism and Diabetic Retinopathy—A Meta-Analysis Comprising 10,168 Subjects

机译:血管紧张素转换酶(ACE)基因多态性与糖尿病性视网膜病变之间的关联—包含10,168名受试者的荟萃分析

获取原文
           

摘要

Aims—to address the inconclusive findings of the association of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism on risk of diabetic retinopathy (DR), a meta-analysis was conducted. Methods—we conducted a meta-analysis on 4252 DR cases and 5916 controls from 40 published studies by searching electronic databases and reference lists of relevant articles. A random-effects or fixed-effects model was used to estimate the overall and stratification effect sizes on ACE I/D polymorphism on the risk of DR. Results—we found a significant association between the ACE I/D polymorphism and the risk of DR for all genetic model (ID vs. II: OR = 1.14, 95% CI: 1.00–1.30; DD vs. II: OR = 1.38, 95% CI: 1.11–1.71; Allele contrast: OR = 1.17, 95% CI: 1.05–1.30; recessive model: OR = 1.24, 95% CI: 1.02–1.51 and dominant model: OR = 1.21, 95% CI: 1.06–1.38, respectively). In stratified analysis by ethnicity and DM type, we further found that the Asian group with T2DM showed a significant association for all genetic models (ID vs. II: OR = 1.14, 95% CI: 1.01–1.30; DD vs. II: OR = 1.54, 95% CI: 1.14–2.08; Allele contrast: OR = 1.26, 95% CI: 1.09–1.47; recessive model: OR = 1.42, 95% CI: 1.07–1.88 and dominant model: OR = 1.26, 95% CI: 1.07–1.49, respectively). Conclusion—our study suggested that the ACE I/D polymorphism may contribute to DR development, especially in the Asian group with type 2 diabetes mellitus (T2DM). Prospective and more genome-wide association studies (GWAS) are needed to clarify the real role of the ACE gene in determining susceptibility to DR.
机译:目的—为了解决血管紧张素转换酶(ACE)插入/缺失(I / D)多态性与糖尿病性视网膜病变(DR)风险相关的不确定性结果,进行了荟萃分析。方法-我们通过搜索电子数据库和相关文章的参考清单,对40篇已发表研究的4252例DR病例和5916例对照进行了荟萃分析。使用随机效应或固定效应模型来估计ACE I / D多态性对DR风险的总体和分层效应大小。结果-我们发现ACE I / D多态性与所有遗传模型的DR风险之间存在显着关联(ID与II:OR = 1.14,95%CI:1.00-1.30; DD与II:OR = 1.38, 95%CI:1.11-1.71;等位基因对比:OR = 1.17,95%CI:1.05-1.30;隐性模型:OR = 1.24,95%CI:1.02-1.51和显性模型:OR = 1.21,95%CI:1.06 –1.38)。在按种族和DM类型进行的分层分析中,我们进一步发现,患有T2DM的亚洲人群对所有遗传模型均显示出显着关联(ID与II:OR = 1.14,95%CI:1.01-1.30; DD与II:OR = 1.54,95%CI:1.14–2.08;等位基因对比:OR = 1.26,95%CI:1.09–1.47;隐性模型:OR = 1.42,95%CI:1.07-1.88,显性模型:OR = 1.26,95% CI:分别为1.07-1.49)。结论—我们的研究表明ACE I / D多态性可能有助于DR的发展,特别是在亚洲2型糖尿病(T2DM)组中。需要前瞻性和更多的全基因组关联研究(GWAS)来阐明ACE基因在确定对DR的敏感性中的真正作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号